- Joined
- 27 June 2010
- Posts
- 4,324
- Reactions
- 367
No comments on one of the best trending stocks (+125%) on the ASX in 2018.
The only question, can it continue?
The chart below is part of a research project and should not be considered a recommendation to buy this stock. If you want to read more about the project log in to read the P2 Weekly Portfolio thread.
Setup: Bouncing off recent consolidation and has now formed a continuation pattern.
Grade A
Conditional order to buy BO-NH, iSL 3.95, initial target 4.70
View attachment 91682
The $2.50 per share proposal is an attempt from Bravura, which listed on the ASX for the second time in 2016 and is worth $1.1 billion, to get GBST to open up its books and grant the company an eight week due diligence period.
Another one of those yesterday:Gap down noted.
Noticed the reversal opportunity in BVS in the daily charts. Then looked at the ugly gap down that happened as BVS reported their FY21 results.
How true.... took one and a half pages to get to the meat (rancid as it is)BVS mgt need to get their heads out of the sand and listen to their customers. This should be fixable if mgt can apply some commonsense and cut the gobbledygook.
yes i saw the ann. earlier ( i think it was down 63% at the time )well, that's nothing. Look at market reaction to the 2022 update.
View attachment 148786
How true.... took one and a half pages to get to the meat (rancid as it is)
However, in the course of undertaking Bravura’s strategic review and assessing our current and expected performance flowing through to the FY23 budget process, it has become clear that the FY23 performance will be below market expectation.
Group revenue is expected to increase modestly in FY23 over the prior year (A$266.7m in FY22).
The trend of lower customer spend on existing and new project work post COVID in EMEA is expected to continue as customers adopt a cautious approach to spend. In addition, three legacy customer contracts are winding down during this year with the majority of revenue impact in FY24. There are no other long term contracts believed to be at risk.
FY23 Guidance
The cumulative impact of the factors discussed above, and allowing for additional costs associated with one off initiatives from the Strategic Review, is that Bravura is expecting its FY23 earnings to differ materially from analysts’ consensus forecasts. With modest revenue growth of between $270 to $275 million, and increase in the FY23 cost base, Bravura now expects to deliver EBITDA of between $10 and $15 million and NPAT to be within the range of ($5M) to $0. The H1 result is expected to reflect lower run rate revenue which is expected to build into the second half, however, costs are expected to remain broadly consistent across the year.
IE. make a loss
I expect there’s quite a few retail traders or investors who won’t touch anything not in whatever index too. Eg they only look within the ASX300 or whatever.could this wobble lower falling out of the various indexes compelling some instos to sell completely
yes scurrying around in the small caps/micro caps ( but still looking for something paying a div. or very likely to pay a div. ) paid off several times back in 2011,2012, 2013 , stocks like ASW , so the occasional search might still pay offI expect there’s quite a few retail traders or investors who won’t touch anything not in whatever index too. Eg they only look within the ASX300 or whatever.
Looking at zero profit and zero dividends. The economy has not exactly shown any strength in the last month or two so I can't imagine their outlook has improved - probably only worsened. Still has a ~ $200 million market cap, and about $70 million in net tangible assets - However this will likely drop as cashflow was forecast to be negative.well, that's nothing. Look at market reaction to the 2022 update.
View attachment 148786
How true.... took one and a half pages to get to the meat (rancid as it is)
However, in the course of undertaking Bravura’s strategic review and assessing our current and expected performance flowing through to the FY23 budget process, it has become clear that the FY23 performance will be below market expectation.
Group revenue is expected to increase modestly in FY23 over the prior year (A$266.7m in FY22).
The trend of lower customer spend on existing and new project work post COVID in EMEA is expected to continue as customers adopt a cautious approach to spend. In addition, three legacy customer contracts are winding down during this year with the majority of revenue impact in FY24. There are no other long term contracts believed to be at risk.
FY23 Guidance
The cumulative impact of the factors discussed above, and allowing for additional costs associated with one off initiatives from the Strategic Review, is that Bravura is expecting its FY23 earnings to differ materially from analysts’ consensus forecasts. With modest revenue growth of between $270 to $275 million, and increase in the FY23 cost base, Bravura now expects to deliver EBITDA of between $10 and $15 million and NPAT to be within the range of ($5M) to $0. The H1 result is expected to reflect lower run rate revenue which is expected to build into the second half, however, costs are expected to remain broadly consistent across the year.
IE. make a loss
$138 million MC now... suddenly that NTA figure is looking more attractive... ??Looking at zero profit and zero dividends. The economy has not exactly shown any strength in the last month or two so I can't imagine their outlook has improved - probably only worsened. Still has a ~ $200 million market cap, and about $70 million in net tangible assets - However this will likely drop as cashflow was forecast to be negative.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?